Shenzhen Ionova Life Sciences Co., Ltd.

This study is testing a new drug called INV-9956 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies and chemotherapy. The first part aims to find a safe dose, and the second part will look for early signs that the drug …

This early-stage study is testing a new cancer drug called INV-1120, both by itself and combined with an existing immunotherapy (pembrolizumab), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe dose levels a…